Survival of Adjuvant Chemotherapy Among Elderly Patients with Stage II Colon Cancer

Survival of Adjuvant Chemotherapy Among Elderly Patients with Stage II Colon Cancer

Summary: Background: There have been few previous studies regarding survival and predictive factors for elderly patients with stage II colon cancer who also undergo surgery. This study examined the effects of adjuvant chemotherapy (AC) on long-term survival among elderly patients with stage II colo...

Full description

Bibliographic Details
Main Authors:	Tsung-Chih Tsai, Jia-Ling Sun, Wen-Li Lin, Sung-Wei Lee, Shu-Chan Chang, Pei-Hua Wu, Wen-Tsung Huang, Chao-Jung Tsao
Format:	Article
Language:	English
Published:	Taiwan Society of Geriatric Emergency and Critical Medicine (TSGECM) 2018-06-01
Series:	International Journal of Gerontology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873959816301430

Similar Items

Adjuvant Chemotherapy Benefit in Elderly Stage II/III Colon Cancer Patients
by: Xin Chen, et al.
Published: (2022-06-01)

Prognostic Factor and Survival Benefit of Adjuvant Chemotherapy in Stage IIA Colon Cancer
by: Mok-Won Lee, et al.
Published: (2021-02-01)

Differential impacts of clinical variables and 5-fluorouracil-based adjuvant chemotherapy on 5-year disease-free survival of patients with stage IIa and IIb colon cancer
by: Yi-Hung Kuo, et al.
Published: (2018-01-01)

Adjuvant chemotherapy in patients with stage II colon cancer
by: Hyung Jin Kim
Published: (2018-12-01)

Improved overall survival is associated with adjuvant chemotherapy after definitive concurrent chemoradiotherapy for N3 nasopharyngeal cancer
by: Mu-Hung Tsai, et al.
Published: (2022-08-01)

Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study
by: Peng Gao, et al.
Published: (2018-03-01)

Adjuvant chemotherapy improves survival in high-risk stage II colon cancer: a retrospective cohort study
by: Lin-Lin Liu, et al.
Published: (2022-11-01)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
by: Safiya Karim, et al.
Published: (2019-09-01)

Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer.
by: Young Shin Chung, et al.
Published: (2017-01-01)

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
by: Jianping Guo, et al.
Published: (2023-10-01)

High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemotherapy
by: I-Ping Yang, et al.
Published: (2019-08-01)

The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
by: Alex Croese, et al.
Published: (2021-06-01)

Adjuvant chemotherapy for stage II colon cancer: less complicated than we thought.
by: Midgley, R, et al.
Published: (2013)

Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
by: Daniel Boakye, et al.
Published: (2021-04-01)

Impact of subsequent chemotherapy on the survival of elderly patients with extensive stage small cell lung cancer
by: Eun Joo Kang, et al.
Published: (2020-11-01)

Postoperative Adjuvant Chemotherapy Regimen of CAPOX Combined With Ninjin'yoeito in an Elderly Patient With Stage III Colon Cancer: A Case Report
by: Naoki Aomatsu, et al.
Published: (2020-04-01)

Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
by: Huabin Hu, et al.
Published: (2020-12-01)

Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival
by: Jieun Kim, et al.
Published: (2021-06-01)

Influence of adjuvant chemotherapy on survival for patients with completely resected high-risk stage IB NSCLC
by: Zi-Qing Shen, et al.
Published: (2024-01-01)

LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
by: Yun-Ting Lou, et al.
Published: (2014-01-01)

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer
by: Pei Zhang, et al.
Published: (2021-01-01)

Cost‐effectiveness of adjuvant chemotherapy for high‐risk stage II and stage III colon cancer in South Africa
by: Sarah Xinhui Tan, et al.
Published: (2023-07-01)

Inadequate Lymph Node Yield: An Inadequate Indication for Adjuvant Chemotherapy in Stage II Colon Cancer
by: Alan Zambeli-Ljepović, MD, MHS, et al.
Published: (2023-12-01)

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer
by: Po-Huang Chen, et al.
Published: (2022-12-01)

Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.
by: Chieh-Sheng Lu, et al.
Published: (2015-01-01)

Diabetes Alone should not be a Reason for Withholding Adjuvant Chemotherapy for Stage III Colon Cancer
by: Maren A. van Waalwijk, et al.
Published: (2011-01-01)

Adjuvant Chemotherapy in Elderly Patients with Early-stage Non-small Cell Lung Cancer
by: Umut KEFELİ, et al.
Published: (2019-10-01)

Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients
by: Yujin Lee, et al.
Published: (2021-10-01)

Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study
by: Hidetaka Kawamura, et al.
Published: (2020-01-01)

Sustainable Clinical Development of Adjuvant Chemotherapy for Colon Cancer
by: Eiji Oki, et al.
Published: (2022-01-01)

Adjuvant colon cancer chemotherapy: Is there an Indian standard of care?
by: Rohit Joshi
Published: (2013-01-01)

Quality of life changes during adjuvant chemotherapy in patients with colon cancer
by: Seo Hee Lee, et al.
Published: (2016-06-01)

The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study
by: Purdie Gordon, et al.
Published: (2009-04-01)

Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy
by: Kevin Chih-Yang Huang, et al.
Published: (2020-12-01)

Differences in prognosis and underuse of adjuvant chemotherapy between elderly and non‐elderly patients in stage III colorectal cancer
by: Takuya Shiraishi, et al.
Published: (2023-01-01)

Real-life experiences and barriers to adjuvant chemotherapy in Saudi patients with advanced stage II and stage III colon cancer
by: Mesnad S Alyabsi, et al.
Published: (2024-01-01)

Socioeconomic and geographic variation in adjuvant chemotherapy among elderly patients with stage III colon cancer in Norway – a national register-based cohort study
by: Elin Marthinussen Gustavsen, et al.
Published: (2024-12-01)

Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review
by: Yat Hang To, et al.
Published: (2023-01-01)

Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base
by: Shiva Kumar R. Mukkamalla, et al.
Published: (2020-09-01)

Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals
by: Yoanna Pumpalova, et al.
Published: (2021-12-01)